A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections
一项随机、双盲、多中心临床研究，比较洛匹那韦/利托那韦-阿奇霉素、洛匹那韦/利托那韦-多西环素和阿奇霉素-羟氯喹三种药物组合对轻度至中度 COVID-19 感染患者的疗效和安全性。
期刊:Biochemistry Research International
影响因子:3.4
doi:10.1155/2021/6685921
Purwati; Budiono; Rachman, Brian Eka; Yulistiani; Miatmoko, Andang; Nasronudin; Lardo, Soroy; Purnama, Yongki Iswandi; Laely, Mafidhatul; Rochmad, Ike; Ismail, Taufik; Wulandari, Sri; Setyawan, Dwi; Rosyid, Alfian Nur; Setiawan, Herley Windo; Wulaningrum, Prastuti Asta; Asmarawati, Tri Pudy; Marfiani, Erika; Yuniati, Shinta Karina; Fuadi, Muhammad Rabiul; Endraswari, Pepy Dwi; Purwaningsih; Hendrianto, Eryk; Karsari, Deya; Dinaryanti, Aristika; Ertanti, Nora; Ihsan, Igo Syaiful; Purnama, Disca Sandyakala; Indrayani, Yuni
